These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17894090)

  • 21. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.
    Fann WE; Lake CR
    Am J Psychiatry; 1976 Aug; 133(8):940-3. PubMed ID: 782262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of donepezil on tardive dyskinesia.
    Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT
    J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 24. A patient with proximal myotonic myopathy and parkinsonism.
    Chu K; Cho JW; Song EC; Jeon BS
    Can J Neurol Sci; 2002 May; 29(2):188-90. PubMed ID: 12035844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiology of static tremor in Parkinsonism].
    Stern P; Catović S
    Neuropsihijatrija; 1964; 12(1-4):7-10. PubMed ID: 16305149
    [No Abstract]   [Full Text] [Related]  

  • 26. A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.
    Park H; Jeon BS; Shin JH; Park SH
    Parkinsonism Relat Disord; 2016 Jan; 22():106-7. PubMed ID: 26613966
    [No Abstract]   [Full Text] [Related]  

  • 27. Tardive dyskinesia and pseudo-parkinsonism. In a nursing home patient who itched.
    Ondo WG; Hurwitz BJ
    N C Med J; 1993 Nov; 54(11):605-7. PubMed ID: 8272117
    [No Abstract]   [Full Text] [Related]  

  • 28. Benign tremulous parkinsonism: a clinicopathological study.
    Rajput AH; Robinson CA; Rajput AH
    Mov Disord; 2008 Jan; 23(2):311-2. PubMed ID: 18044768
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Hunter C; Jankovic J
    Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sleep disorders and parkinsonian syndromes].
    Monaca C
    Rev Neurol (Paris); 2008 Dec; 164(12 Suppl):F253-62. PubMed ID: 19268188
    [No Abstract]   [Full Text] [Related]  

  • 31. Not Parkinson's disease: neurologists' mistakes with a diversion into adult hydrocephalus.
    Jellinek EH
    Pract Neurol; 2008 Oct; 8(5):322-4. PubMed ID: 18796588
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced cranial myoclonus.
    Gupta A; Lang AE
    Mov Disord; 2010 Oct; 25(13):2264-5. PubMed ID: 20740488
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A; Li Q; Gardoni F; Marcello E; Qin C; Carlsson T; Kirik D; Di Luca M; Björklund A; Bezard E; Carta M
    Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Parkinsonism: collaboration between the physician and the neurologist].
    Vingerhoets F
    Rev Med Suisse Romande; 2000 Sep; 120(9):709-16. PubMed ID: 11094535
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
    Ohta K; Obara K
    Mov Disord; 2006 Jan; 21(1):124-5. PubMed ID: 16229001
    [No Abstract]   [Full Text] [Related]  

  • 36. Amantadine-associated corneal edema.
    Ghaffariyeh A; Honarpisheh N
    Parkinsonism Relat Disord; 2010 Jul; 16(6):427. PubMed ID: 20350832
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-induced parkinsonism].
    Shiio Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():377-81. PubMed ID: 18072346
    [No Abstract]   [Full Text] [Related]  

  • 39. L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasm.
    Wick W; Hochberg F; O'Sullivan J; Goessling A; Hughes A; Cher L
    Oncol Rep; 2000; 7(6):1367-70. PubMed ID: 11032946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.